Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
Active, not recruiting · NCT05777031 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease | Genital Diseases, Male Urogenital Diseases, Peyronie disease, Sexual Dysfunctions, Psychological, Skin and Connective Tissue Diseases, Urogenital Diseases, connective tissue disorder, male reproductive system disorder, penile disorder, psychiatric disorder | Active, not recruiting | Phase 4 | 2026-06-04 | NCT05777031 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Endo USA Inc., a Keenova Therapeutics Company | 6 |
| University of Miami | 277 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Miami | Miami | United States | 327 |
| University of Miami - Desai Sethi Urology Institute | Miami | United States | 1 |